Ob-Gyn Coding Alert

News You Can Use:

Say Goodbye to Surgical Mesh Products for Pelvic Organ Prolapses

FDA has removed mesh products from the market. On April 16, the FDA decided to eliminate mesh as a potential option for patients suffering from pelvic organ prolapse (POP) or stress urinary incontinence (SUI). That means you shouldn’t see any more transvaginal repair of anterior compartment (cystocele) claims featuring mesh. If you do, you could likely expect to see a [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.